Neuroimmunology
Ocrelizumab
Mar. 17, 2021
MedLink®, LLC
3525 Del Mar Heights Rd, Ste 304
San Diego, CA 92130-2122
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Toll Free (U.S. + Canada): 800-452-2400
US Number: +1-619-640-4660
Support: service@medlink.com
Editor: editor@medlink.com
ISSN: 2831-9125
Nearly 3,000 illustrations, including video clips of neurologic disorders.
Every article is reviewed by our esteemed Editorial Board for accuracy and currency.
Full spectrum of neurology in 1,200 comprehensive articles.
Listen to MedLink on the go with Audio versions of each article.
Mean annual rate by state for adults with blood lead levels 40 µg/dL or higher in 20 Adult Blood Lead Epidemiology and Surveillance (ABLES) Program states reporting data for 2 or more years in each period.
Note: South Carolina, 3 years of data (1998-2001); Ohio and Pennsylvania, 2 years of data; Alabama, Iowa, and Minnesota, 3 years of data (1994-1997).
(Source: Bureau of Labor Statistics, Current Population Survey, 2001. Centers for Disease Control and Prevention. Adult blood lead epidemiology and surveillance--United States, 2002. MMWR Morb Mortal Wkly Rep 2004;53[26]:578-82.)